tenofovir has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdеlaziz, RR; Abouelezz, HM; El-Kashef, DH; Nader, MA | 1 |
1 other study(ies) available for tenofovir and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Tenofovir alone or combined with doxorubicin abrogates DMBA-induced mammary cell carcinoma: An insight into its modulatory impact on oxidative/Notch/apoptotic signaling.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Biomarkers, Tumor; Carcinoma; Doxorubicin; Oxidative Stress; Rats; Tenofovir | 2023 |